Literature DB >> 23403260

p15Ink4b Functions in determining hematopoietic cell fates: implications for its role as a tumor suppressor.

Linda Wolff1, Juraj Bies.   

Abstract

The p15Ink4b gene is frequently hypermethylated in myeloid neoplasia and has been demonstrated to be a tumor suppressor. Since it is a member of the INK4b family of cyclin-dependent kinase inhibitors, it was initially presumed that its loss in leukemic blasts caused a dysregulation of the cell cycle. However, animal model experiments over the last several years have produced a very different picture of how p15Ink4b functions in hematopoietic cells and how its loss contributes to myelodysplastic syndrome and myeloid leukemia. It is clear now, that in early hematopoietic progenitors, p15Ink4b functions outside of its canonical role as a cell cycle inhibitor. Its functions are involved in signal transduction and influence the development of erythroid, monocytic and dendritic cells. Published by Elsevier Inc.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23403260      PMCID: PMC7581278          DOI: 10.1016/j.bcmd.2013.01.006

Source DB:  PubMed          Journal:  Blood Cells Mol Dis        ISSN: 1079-9796            Impact factor:   3.039


  43 in total

Review 1.  CDK inhibitors: positive and negative regulators of G1-phase progression.

Authors:  C J Sherr; J M Roberts
Journal:  Genes Dev       Date:  1999-06-15       Impact factor: 11.361

2.  Roles of PU.1 in monocyte- and mast cell-specific gene regulation: PU.1 transactivates CIITA pIV in cooperation with IFN-gamma.

Authors:  Tomonobu Ito; Chiharu Nishiyama; Nobuhiro Nakano; Makoto Nishiyama; Yoshihiko Usui; Kazuyoshi Takeda; Shunsuke Kanada; Kanako Fukuyama; Hisaya Akiba; Tomoko Tokura; Mutsuko Hara; Ryoji Tsuboi; Hideoki Ogawa; Ko Okumura
Journal:  Int Immunol       Date:  2009-06-05       Impact factor: 4.823

3.  Distinct patterns of inactivation of p15INK4B and p16INK4A characterize the major types of hematological malignancies.

Authors:  J G Herman; C I Civin; J P Issa; M I Collector; S J Sharkis; S B Baylin
Journal:  Cancer Res       Date:  1997-03-01       Impact factor: 12.701

4.  Involvement of STAT-1 and ets family members in interferon-gamma induction of CD40 transcription in microglia/macrophages.

Authors:  V T Nguyen; E N Benveniste
Journal:  J Biol Chem       Date:  2000-08-04       Impact factor: 5.157

5.  Alterations of INK4A and INK4B genes in adult soft tissue sarcomas: effect on survival.

Authors:  I Orlow; M Drobnjak; Z F Zhang; J Lewis; J M Woodruff; M F Brennan; C Cordon-Cardo
Journal:  J Natl Cancer Inst       Date:  1999-01-06       Impact factor: 13.506

6.  Loss of the tumor suppressor p15Ink4b enhances myeloid progenitor formation from common myeloid progenitors.

Authors:  Michael Rosu-Myles; Barbara J Taylor; Linda Wolff
Journal:  Exp Hematol       Date:  2007-03       Impact factor: 3.084

7.  Methylation of p15INK4B is common, is associated with deletion of genes on chromosome arm 7q and predicts a poor prognosis in therapy-related myelodysplasia and acute myeloid leukemia.

Authors:  D H Christiansen; M K Andersen; J Pedersen-Bjergaard
Journal:  Leukemia       Date:  2003-09       Impact factor: 11.528

8.  The role of tumor suppressor p15Ink4b in the regulation of hematopoietic progenitor cell fate.

Authors:  R Humeniuk; M Rosu-Myles; J Fares; R Koller; J Bies; L Wolff
Journal:  Blood Cancer J       Date:  2013-01-04       Impact factor: 11.037

9.  Circulating myeloid and lymphoid precursor dendritic cells are clonally involved in myelodysplastic syndromes.

Authors:  L Ma; M Delforge; V van Duppen; G Verhoef; B Emanuel; M Boogaerts; A Hagemeijer; P Vandenberghe
Journal:  Leukemia       Date:  2004-09       Impact factor: 11.528

Review 10.  Review of alterations of the cyclin-dependent kinase inhibitor INK4 family genes p15, p16, p18 and p19 in human leukemia-lymphoma cells.

Authors:  H G Drexler
Journal:  Leukemia       Date:  1998-06       Impact factor: 11.528

View more
  10 in total

1.  C/EBPα is an essential collaborator in Hoxa9/Meis1-mediated leukemogenesis.

Authors:  Cailin Collins; Jingya Wang; Hongzhi Miao; Joel Bronstein; Humaira Nawer; Tao Xu; Maria Figueroa; Andrew G Muntean; Jay L Hess
Journal:  Proc Natl Acad Sci U S A       Date:  2014-06-23       Impact factor: 11.205

2.  Loss of CDKN2B Promotes Fibrosis via Increased Fibroblast Differentiation Rather Than Proliferation.

Authors:  Anne M Scruggs; Hailey B Koh; Priya Tripathi; Nicholas J Leeper; Eric S White; Steven K Huang
Journal:  Am J Respir Cell Mol Biol       Date:  2018-08       Impact factor: 6.914

3.  Brief report: Loss of p15Ink4b accelerates development of myeloid neoplasms in Nup98-HoxD13 transgenic mice.

Authors:  Rita Humeniuk; Richard Koller; Juraj Bies; Peter Aplan; Linda Wolff
Journal:  Stem Cells       Date:  2014-05       Impact factor: 6.277

4.  Long non-coding RNA IRAIN suppresses apoptosis and promotes proliferation by binding to LSD1 and EZH2 in pancreatic cancer.

Authors:  Yifan Lian; Juan Wang; Jing Feng; Jie Ding; Zhonghua Ma; Juan Li; Peng Peng; Wei De; Keming Wang
Journal:  Tumour Biol       Date:  2016-09-19

Review 5.  Role of HOXA9 in leukemia: dysregulation, cofactors and essential targets.

Authors:  C T Collins; J L Hess
Journal:  Oncogene       Date:  2015-06-01       Impact factor: 9.867

6.  Rapamycin restores p14, p15 and p57 expression and inhibits the mTOR/p70S6K pathway in acute lymphoblastic leukemia cells.

Authors:  Huibo Li; Xiaolin Kong; Gang Cui; Cuicui Ren; Shengjin Fan; Lili Sun; Yingjie Zhang; Rongyi Cao; Yinghua Li; Jin Zhou
Journal:  Int J Hematol       Date:  2015-09-11       Impact factor: 2.490

Review 7.  The involvement of lncRNAs in the development and progression of pancreatic cancer.

Authors:  Li Duguang; He Jin; Qian Xiaowei; Xu Peng; Wang Xiaodong; Li Zhennan; Qian Jianjun; Yao Jie
Journal:  Cancer Biol Ther       Date:  2017-11-27       Impact factor: 4.742

8.  Clinicopathological significance of p15 promoter hypermethylation in multiple myeloma: a meta-analysis.

Authors:  Bing Wei; Shuhua Yang; Bo Zhang; Yong Feng
Journal:  Onco Targets Ther       Date:  2016-07-01       Impact factor: 4.147

9.  Long non-coding RNA SNHG15 inhibits P15 and KLF2 expression to promote pancreatic cancer proliferation through EZH2-mediated H3K27me3.

Authors:  Zhonghua Ma; Hesuyuan Huang; Jirong Wang; Yan Zhou; Fuxing Pu; Qinghong Zhao; Peng Peng; Bingqing Hui; Hao Ji; Keming Wang
Journal:  Oncotarget       Date:  2017-08-18

10.  CDKL1 promotes tumor proliferation and invasion in colorectal cancer.

Authors:  Chunzhi Qin; Li Ren; Meiling Ji; Shixu Lv; Ye Wei; Dexiang Zhu; Qi Lin; Pingping Xu; Wenju Chang; Jianmin Xu
Journal:  Onco Targets Ther       Date:  2017-03-16       Impact factor: 4.147

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.